EORTC Presentations at ISOQOL 2016 in Copenhagen

The EORTC will present 18 abstracts at the ISOQOL 2016 Annual Meeting which will be held 19 – 22 October 2016 in Copenhagen, Denmark. eight abstracts will be presented in Oral Abstract Sessions, eight in General Poster Sessions.

These presentations are on behalf of or funded by the EORTC QLG and we are proud to see that EORTC has such a record number of abstracts selected for the ISOQOL 23rd Annual Conference.

These abstracts are a perfect illustration of the rapid increase in research and success of collaboration between the EORTC Quality of Life Group, the department, the EORTC Disease-Oriented Groups and other important international collaborators.

Oral Abstract Sessions

A Systematic Review on the Choice and Implementation of Statistical Methods in Health-Related Quality of Life Data Analyses in Locally Advanced and Metastatic Breast Cancer Randomized Controlled Trials (SISAQOL Consortium)

Oral Session 101: Guidelines and Standards (101.4), Thu 20.10.2016, 2:32 pm – 2:45 pm

Authors: Madeline Pe , Andrew Bottomley, Franck Bonnetain, Alicyn Campbell, Laurence Collette, Amylou Dueck, Nancy Devlin, Carolyn Gotay, Eva Greimel, Mogens Groenvold, Jean-François Hamel, Madeleine King, Francesca Martinelli, Sandra Mitchell, Carol Moinpour, Jammbe Musoro, Chantal Quinten, Melanie Calvert, Henning Flechtner, Martin Taphoorn, Corneel Coens

Setting Standards for Analysis of Quality of Life Data for International Cancer Clinical Trials (SISAQOL Consortium)

Oral Session 101: Guidelines and Standards (101.45), Thu 20.10.2016, 2:32 pm – 2:45 pm

Authors: Corneel Coens , Madeline Pe, Jeff Sloan, Ethan Basch, Charles Cleeland, Kim Cocks, David Collingridge, Ingolf Griebsch, Michael Koller, Daniel Malone, Daniel O’Connor, Kathy Oliver, Elisabeth PiaultLouis, Martine Piccart, Francisco Pimentel, Jaap Reijneveld, Christoph Schuermann, Ashley Smith, Galina Velikova, Andrew Bottomley

Is there a relationship between spiritual wellbeing (SWB) and emotional and physical functioning for people receiving palliative care for cancer?

Oral Session 103: Cancer I (103.4), Thu 20.10.2016, 2:32 pm – 2:45 pm

Authors: Gudrun Rohde, Teresa Young, Julie Winstanley, Juan I. Arraras, Kath Black, Anne Bredart, Anna Costantini, Sheila Fisher, Jingbo Guo, M. Elisa Irarrazaval, Kunihiko Kobayashi, Renske Kruizinga, Mariana Navarro, Sepideh Omidvari, Samantha Serpentini, Nigel Spry, Hanneke W. van Laarhoven, Grace Yang, Bella Vivat

Development of thresholds for clinical importance for the EORTC quality of life measures

Oral Session 202: Score Interpretation (202.3), Fri 21.10.2016,  2:33 pm – 2:46 pm

Authors: Johannes M. Giesinger, Neil K. Aaronson, Juan I. Arraras, Fabio Efficace, Elizabeth Friend, Mogens Gronvold, Jacobien M Kieffer, Fanny LC Loth, Morten Aa. Petersen, Krzysztof A. Tomaszewski, Teresa Young, Bernhard Holzner

Empirical Evaluation of the Minimal Important Differences (MID) with the EORTC Quality of Life Group Measures: Embarking on a New Research Initiative on behalf of the EORTC Quality of Life Group and EORTC Quality of Life Department.

Oral Session 202: Score Interpretation (202.5), Fri 21.10.2016, 3:01 pm – 3:14 pm

Authors: Musoro J, Coens C, Ediebah E, Eggermont A, Flechtner H, Greimel E, Groenvold M, King M, Piccart-Gebhart M, Reijneveld JC, Smit E, Sprangers M, Stupp R, Taphoorn M, Velikova G, Zikos E, Bottomley A

An item response theory based method for detecting item-level response-shift

Oral Session 301 Response Shift (301.3), Sat 22.10.2016,  4:23 pm – 4:36 pm

Authors: Jean-Francois Hamel

Evidence for the content validity of the EORTC QLQ-C30: Review of existing data

Oral Session 303: Content Validity (303.4), Sat 22.10.2016,  4:37 pm – 4:50 pm

Authors: Kim Cocks, Chloe Tolley, Laura Grant, Sally Wheelwright, Krzysztof Tomaszewski, Mogens Groenvold, Andrew Bottomley, Deborah Fitzsimmons, Galina Velikova, Neil Aaronson, Colin Johnson

International phase 4 validation of the EORTC Patient-Reported Outcome Measure (PROM) in breast reconstruction (BRR): Evaluating the psychometric properties  and clinical effectiveness.

Oral Session 302: Cancer III (302.5), Sat 22.10.2016, 4:51 pm – 5:04 pm

Authors: Winters ZE, Afzal M, Rumpold G, Holzner B, Oberguggenburger A, Vieira RAC, Hartnup S, Filcroft K, Bjelic-Radisic V, Panouilleres M, Rydevik Mani M, King MT, Rutherford C

General Poster Sessions

THE EORTC COMMUNICATION-QUESTIONNAIRE: Preliminary results of Phase III and design of the validation study for the EORTC QLQ-COMU26

Details: Poster Session I Cancer Instrument (1053), Thu 20.10.2016

Authors: Juan I. Arraras, Oncology Departments, Complejo Hospitalario de Navarra, Pamplona, Spain, Monika Sztankay, MSc, Medical University of Innsbruck, Innsbruck, Austria; Lisa M. Wintner, MSc, Medical University of Innsbruck, Innsbruck, Austria; Krzysztof Tomaszewski, Department of Anatomy, Jagiellonian University Medical College, Krakow, Poland; Dirk Hofmeister, University of Leipzig, Leipzig, Germany., Leipzig, Germany; Anna Costantini, Psychoncology Unit, Department of Oncological Sciences, Rome, Italy; Anne Bredart, Psychiatry and Psychooncology Unit, Institut Curie, Paris, France; Teresa Young, Lynda Jackson Macmillan Centre, Mount Vernon Cancer Centre, Northwood, Middlesex, United Kingdom; Karin Kuljanic, University Hospital Center Rijeka, Rijeka, Croatia; Iwona M. Tomaszewska, Jagiellonian University Medical College, Krakow, Poland; Meropi Kontogianni, Harokopio University, Athens, Greece; Wei-Chu Chie, Institute of Epidemiology and Preventive Medicine and Department of Public Health, College of Public Health, National Taiwan University, Taipei, Republic of Taiwan; Dagmara Kulis, EORTC, Brussels, Belgium; Eva Greimel, University Hospital Graz, Graz, Austria

Comparison of German, French and Polish Utility Weights for the EORTC Utility Instrument QLU-C10D

Details: Poster Session I Cancer Instrument  (1027), Thu 20.10.2016

Authors: Georg Kemmler, Innsbruck Medical University, Innsbruck, Tyrol, Austria; Eva Gamper, PhD, Medical University of Innsbruck, Innsbruck, Tyrol, Austria; Virginie Nerich, Besançon University Hospital, Besançon, France; Madeleine King, PhD, University of Sydney, Sydney, NSW, Australia; Richard Norman, Curtin University, Perth, Australia; Bernhard Holzner, PhD, Medical University of Innsbruck, Innsbruck, Austria

An initial international validation of the EORTC computer adaptive test (CAT) confirmed feasibility

Details: Poster Session I Cancer Instrument (1045), Thu 20.10.2016

Authors: Morten Aa. Petersen, Neil K. Aaronson, Andreas Boehm, Wei-Chu Chie, Anna Costantini, Liz Friend, Johannes Giesinger, Bernhard Holzner, Jacobien M. Kieffer, Sandra Nolte, Krzysztof A. Tomaszewski, Teresa Young, Mogens Groenvold on behalf of the EORTC Quality of Life Group

Update of the EORTC questionnaire for assessing quality of life in patients with lung cancer – introducing the new EORTC QLQ-Lung Cancer 29 module

Details: Poster Session I  Cancer Instrument (1009), Thu 20.10.2016

Authors: Andrew Bottomley, Marianne Hjermstad, Krzysztof Tomaszewski, Amelie Harle, Juan Arraras, Ofir Morag, Cecilia Pompili, Georgios Ioannidis, Loukia Georgiou, Morfo Georgiou, Chiara Navarra, Wei-Chu Chie, Colin Johnson, Ayje Himpel, Christian Schulz, Hans-Stefan Hofmann, Dagmara Kulis, Michael Koller

Comparison of the FACT-C, EORTC QLQ-CR38 and QLQ-CR29 quality of life: a review

Details: Poster Session I Cancer Instrument (1011), Thu 20.10.2016

Authors: Vithusha Ganesh, Arnav Agarwal, Marko Popovic, David Cella, Rachel McDonald, Sherlyn Vuong, Henry Lam, Leigha Rowbottom, Stephanie Chan, Tasneem Barakat, Carlo DeAngelis, Michael Borean, Edward Chow, Andrew Bottomley

Introducing the new EORTC Quality of Life Group Item Bank

Details: Poster Session I Cancer Instrument (1029), Thu 20.10.2016

Authors: Dagmara Kulis, Cheryl Whittaker, Francesca Martinelli, Tamara Sanchez Panos, Andrew Bottomley, Pascal Ruyskart, Eva Greimel, Deborah Fitzsimmons, Bernhard Holzner, Michael Koller

Challenges of the translation of the EORTC patient satisfaction questionnaires

Details: Poster Session I Cancer Instrument (1031), Thu 20.10.2016

Authors: Dagmara Kulis, Tamara Sanchez Panos, Cheryl Whittaker, Andrew Bottomley, Eva Greimel, Anne Bredart, Michael Koller

A manual for the use of EORTC measures in daily clinical practice

Details: Poster Session I Cancer Instrument (1061), Thu 20.10.2016

Authors: Lisa M. Wintner, Monika Sztankay, Neil Aaronson, Andrew Bottomley, Johannes M. Giesinger, Mogens Groenvold, Morten Aa. Petersen, Lonneke van de Poll-Franse, Galina Velikova, Irma Verdonck-Leeuw, Bernhard Holzner on behalf of the EORTC Quality of Life Group

The collection of norm data for the new EORTC computer-adaptive test (CAT), the QLQ-CAT: what constitutes the “European norm”?

Details: Poster Session I Cancer Instrument (1041), Thu 20.10.2016

Authors: Sandra Nolte, Neil Aaronson, Anna Costantini, Peter Fayers, Mogens Groenvold, Bernhard Holzner, Colin Johnson, Georg Kemmler, Gregor Liegl, Morten A. Petersen, Krzysztof Tomaszewski, Annika Waldmann, Teresa Young, Matthias Rose; on behalf of the EORTC QLG

Quality of life evolution for melanoma patients: a systematic review

Details: Poster Session I Cancer II (3023), Sat 22.10.2016

Authors: Jean-Francois Hamel, Madeline Pe, Jammbe Musoro, Corneel Coens, Andrew Bottomley

Back to news list

Related News

  • EORTC strategic meeting with Middle Eastern Ambassadors

  • EORTC Quality of Life Group projects to be presented at ISOQOL 2023

  • Celebrating Sarcoma Awareness Month with the start of EU-funded STREXIT 2 project study

  • “Best Proposal in Medicine” award received by EORTC at the PTCOG 61 Conference

  • Long-term efficacy and safety outcomes of the EORTC/LYSA/FIL H10 trial assessing early PET-scan adapted treatment of limited stage Hodgkin lymphoma

  • Joint Statement: health organisations define EHDS’ opt out required for life saving research

  • Congratulations to Dr. Hans Wildiers, winner of the B.J. Kennedy Geriatric Oncology Award

  • Full validation of the EORTC CAT Core

  • SISAQOL-IMI: Setting standards for the use of patient-reported outcome data in cancer trials

  • Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types